74 related articles for article (PubMed ID: 3921238)
1. An experimental rat model of local bone cancer invasion and its responsiveness to ethane-1-hydroxy-1,1-bis(phosphonate).
Guaitani A; Sabatini M; Coccioli G; Cristina S; Garattini S; Bartosek I
Cancer Res; 1985 May; 45(5):2206-9. PubMed ID: 3921238
[TBL] [Abstract][Full Text] [Related]
2. Bone invasion by Walker 256 carcinoma, line A in young and adult rats: effects of etidronate.
Bassani D; Sabatini M; Scanziani E; De Francesco L; Coccioli G; Guaitani A; Bartosek I
Oncology; 1990; 47(2):160-5. PubMed ID: 2107481
[TBL] [Abstract][Full Text] [Related]
3. [Feasibility of establishment of rat model of bone cancer pain by using Walker 256 cells cultured in vitro or in vivo].
Yao M; Yang JP; Wang LN; Cheng H; Zhang YB; Xu QN; Wu YW
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(13):880-4. PubMed ID: 18756951
[TBL] [Abstract][Full Text] [Related]
4. Effect of a diphosphonate on the osteoinductive activity of rat bone matrix.
Bauer FC; Nilsson OS; Tornkvist H; Lindholm TC; Lindholm TS
Clin Orthop Relat Res; 1984 May; (185):266-9. PubMed ID: 6423335
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by diphosphonates of bone resorption induced by the Walker tumor of the rat.
Jung A; Bornand J; Mermillod B; Edouard C; Meunier PJ
Cancer Res; 1984 Jul; 44(7):3007-11. PubMed ID: 6233002
[TBL] [Abstract][Full Text] [Related]
6. Effects of propane-2, 2-diphosphonate (PDP) on matrix-induced ectopic bone formation in comparison to ethane-1-hydroxy-1, 1-diphosphonate (EHDP).
Rüther W; Kindermann D; Gebhardt M; Münzenberg KJ
Clin Orthop Relat Res; 1990 Sep; (258):122-34. PubMed ID: 2118435
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effect of samarium-153-labeled ethylenediaminetetramethylene phosphonate (EDTMP) on bone invasion and osteolysis in Walker 256 carcinoma bearing rats].
Shi B; Fu Z; Lei XH
Zhonghua Zhong Liu Za Zhi; 1997 Nov; 19(6):423-6. PubMed ID: 10920873
[TBL] [Abstract][Full Text] [Related]
8. Increased growth rate and tumor burden of spontaneously metastatic Walker 256 cancer cells in the skeleton of bisphosphonate-treated rats.
Kostenuik PJ; Orr FW; Suyama K; Singh G
Cancer Res; 1993 Nov; 53(22):5452-7. PubMed ID: 8221685
[TBL] [Abstract][Full Text] [Related]
9. Prevention of ectopic bone formation by local application of ethane-1-hydroxy-1,1-diphosphonate (EHDP): an experimental study in rabbits.
Ahrengart L; Lindgren U
J Orthop Res; 1986; 4(1):18-26. PubMed ID: 3081698
[TBL] [Abstract][Full Text] [Related]
10. The effect of long-term low-dose diphosphonate treatment on rat bone.
Evans RA; Howlett CR; Dunstan CR; Hills E
Clin Orthop Relat Res; 1982 May; (165):290-9. PubMed ID: 6210482
[TBL] [Abstract][Full Text] [Related]
11. Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice.
Cui N; Nomura T; Noma H; Yokoo K; Takagi R; Hashimoto S; Okamoto M; Sato M; Yu G; Guo C; Shibahala T
Clin Cancer Res; 2005 Apr; 11(7):2713-9. PubMed ID: 15814653
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.
Sasaki A; Boyce BF; Story B; Wright KR; Chapman M; Boyce R; Mundy GR; Yoneda T
Cancer Res; 1995 Aug; 55(16):3551-7. PubMed ID: 7627963
[TBL] [Abstract][Full Text] [Related]
13. Walker 256/S carcinosarcoma causes osteoporosis-like changes through ectopical secretion of luteinizing hormone-releasing hormone.
Waki Y; Nomura M; Kasugai S; Ohya K; Miyamoto K
Cancer Res; 1999 Mar; 59(6):1219-24. PubMed ID: 10096551
[TBL] [Abstract][Full Text] [Related]
14. The bisphosphonate olpadronate inhibits skeletal prostate cancer progression in a green fluorescent protein nude mouse model.
Yang M; Burton DW; Geller J; Hillegonds DJ; Hastings RH; Deftos LJ; Hoffman RM
Clin Cancer Res; 2006 Apr; 12(8):2602-6. PubMed ID: 16638872
[TBL] [Abstract][Full Text] [Related]
15. Effects of disodium etidronate in murine tumor models.
Guaitani A; Polentarutti N; Filippeschi S; Marmonti L; Corti F; Italia C; Coccioli G; Donelli MG; Mantovani A; Garattini S
Eur J Cancer Clin Oncol; 1984 May; 20(5):685-93. PubMed ID: 6428894
[TBL] [Abstract][Full Text] [Related]
16. The effects of long-term administration of ethane-1-hydroxy-1, 1-diphosphonate on osteoarthrosis and heterotopic ossification in the mouse knee joint.
Walton M
Clin Orthop Relat Res; 1981; (155):218-23. PubMed ID: 6784994
[TBL] [Abstract][Full Text] [Related]
17. [On the effect of methane-bis--phosphonate in vivo (author's transl)].
Reimann E; Münzenberg KJ; Gebhardt M
Arzneimittelforschung; 1978; 28(10):1731-3. PubMed ID: 158365
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
19. Autoradiographic studies of rhenium-188-hydroxyethylidine diphosphonate in normal skeleton and osteoblastic bone metastases in a rat model of metastatic prostate cancer.
Liepe K; Geidel HH; Bergmann R; Haase M; Runge R; Kotzerke J
Nucl Med Commun; 2009 Sep; 30(9):693-9. PubMed ID: 19528873
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L
Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
